AFP and neoplasm: Regardless of the tumor size (<5 or ≥5 cm), AFP level (<400 or ≥400 ng/mL), and BCLC stages (0–A, B, C–D), the 3-year OS rate of Huaier users was significantly higher than that of non-Huaier users.